Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9377-9385

  Chung, Maeran ^a   Kizhatil, Krishnakumar ^b   Albritton, Lorraine M ^b   Gaulton, Glen N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; TRYPTOPHAN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BRAIN CAPILLARY; CELL FUSION; CONTROLLED STUDY; ENDOTHELIUM CELL; HOST CELL; HUMAN; HUMAN CELL; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUAIL; RECEPTOR DENSITY; SPECIES DIFFERENCE; SYNCYTIUM; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; XENOTROPIC VIRUS;

EID: 0032826505     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9377-9385.1999     Document Type: Article

References (55)

1. Albritton, L. M., J. W. Kim, L. Tseng, and J. M. Cunningham. 1993. Envelope binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J. Virol. 67:2091-2096.
2. Altieri, D. C., O. R. Etingin, D. S. Fair, T. K. Brunck, J. E. Geltosky, D. P. Hajjar, and T. S. Edgington. 1991. Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors. Science 254:1200-1202.
3. Beilke, M. A. 1989. Vascular endothelium in immunology and infectious disease. Rev. Infect. Dis. 11:273-283.
4. Benditt, E. P., T. Barrett, and J. K. McDougall. 1983. Viruses in the etiology of atherosclerosis. Proc. Natl. Acad. SCi. USA 80:6386-6389.
5. Berson, J. F., D. Long, B. J. Doranz, J. Rucker, F. R. Jirik, and R. W. Doms. 1996. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J. Virol. 70: 6288-6295.
6. Brody, B. A., S. S. Rhee, and E. Hunter. 1994. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 68:4620-4627.
7. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
8. Carneiro, A. V., J. Ferro, C. Figueiredo, L. Costa, J. Campos, and F. dePauda. 1994. Herpes zoster and contralateral hemiplegia in one African patient infected with HIV-1. Acta Med. Port. 4:91-92.
9. Chung, M., and G. N. Gaulton. Unpublished data.
10. Clavel, F., and P. Charneau. 1994. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68:1179-1185.
11. Czub, S., W. P. Lynch, M. Czub, and J. L. Portis. 1994. Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus. Lab. Investig. 70:711-723.
12. DeLarco, J., and G. J. Todaro. 1976. Membrane receptors for murine leukemia virus: characterization using the purified viral envelope glycoprotein, gp71. Cell 8:365-371.
13. Engstrom, J. W., D. H. Lowenstein, and D. E. Bredesen. 1989. Cerebal infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am. J. Med. 86:528-532.
14. Etingin, O. R., R. L. Silverstein, and D. P. Haggar. 1991. Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc. Natl. Acad. Sci. USA 88:7200-7203.
15. Fabricant, C. G. 1985. Atherosclerosis: the consequence of infection with a herpes virus. Adv. Vet. Sci. Comp. Med. 30:39-66.
16. Fass, D., R. A. Davey, C. A. Hamson, P. S. Kim, J. M. Cunningham, and J. M. Berger. 1997. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277:1662-1666.
17. Fish, K., C. Soderberg-Naucler, L. Mills, S. Stenglein, and J. Nelson. 1998. Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 71:5661-5668.
18. Green, N., T. M. Shinnick, O. Witte, A. Ponticelli, J. G. Sutcliffe, and R. A. Lerner. 1981. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78:6023.
19. Hajjar, D. P. 1991. Viral pathogenesis of atherosclerosis. Am. J. Pathol. 139:1195-1211.
20. Januszeski, M. M., P. M. Cannon, D. Chen, Y. Rozenberg, and W. F. Anderson. 1997. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 71:3613-3619.
21. Jones, J. S., and R. Risser. 1993. Cell fusion induced by the murine leukemia virus envelope glycoprotein. J. Virol. 67:67-74.
22. Kaden, M. J., S. Sturm, W. F. Anderson, and M. A. Eglitis. 1992. Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J. Virol. 66:2281-2287.
23. Kizhatil, K., and L. M. Albritton. Unpublished data.
24. Lathey, J., C. Wiley, M. Verity, and J. Nelson. 1990. Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus. Virology 176:266-273.
25. Lynch, W. P., S. Czub, F. J. McAtee, S. F. Hayes, and J. L. Portis. 1991. Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 7:365.
26. MacKrell, A. J., N. W. Soong, C. M. Carmel, and W. F. Anderson. 1996. Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J. Virol. 70:1768-1774.
27. Malhotra, S., A. G. Scott, T. Zavorotinskaya, and L. M. Albritton. 1996. Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry. J. Virol. 70:321-326.
28. Masuda, M., C. A. Hanson, N. V. Dugger, D. S. Robbins, S. G. Wilt, S. K. Ruscetti, and P. M. Huffman. 1997. Capillary endothelial cell tropism of PVC-211 murine leukemia virus and its application for gene transduction. J. Virol. 71:6168-6173.
29. Masuda, M., P. M. Hoffman, and S. K. Ruscetti. 1993. Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro. J. Virol. 67:4580-4587.
30. Melnick, J., B. Petrie, G. Dreesman, J. Burek, C. McCollum, and M. DeBakey. 1983. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet ii:644-647.
31. Nussbaum, O., C. C. Broder, and E. A. Berger. 1994. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:5411-5422.
32. Park, B. H., E. Lavi, K. J. Blank, and G. N. Gaulton. 1993. Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J. Virol. 67:6015-6024.
33. Park, B. H., E. Lavi, and G. N. Gaulton. 1994. Intracerebral hemorrhages and infarction induced by a murine leukemia virus is influenced by host determinants within endothelial cells. Virology 203:393-396.
34. Park, B. H., E. Lavi, A. Stieber, and G. N. Gaulton. 1994. Pathogenesis of cerebral infarction and hemorrhages induced by a murine leukemia virus. Lab. Investig. 71:78-85.
35. Park, B. H., B. Matuschke, E. Lavi, and G. N. Gaulton. 1994. A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease. J. Virol. 68:7516-7524.
36. Pitts, O. M., J. M. Powers, J. A. Bilello, and P. M. Huffman. 1987. Ultrastructural changes associated with retroviral replication in central nervous system capillary endothelial cells. Lab. Investig. 56:401-409.
37. Ragheb, J. A., and W. F. Anderson. 1994. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68:3220-3231.
38. Rawlinsin, W. D., and A. L. Cunningham. 1991. Contralateral hemiplegia following thoracic herpes zoster. Med. J. Aust. 155:344-346.
39. Rein, A., J. Mirro, J. G. Haynes, S. M. Ernst, and K. Nagashima. 1994. Function of the cytoplasmic domain of a retroviral transmemhrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1773-1781.
40. Rice, N. R., L. E. Henderson, R. C. Sowder, T. D. Copeland, S. Oroszlan, and J. F. Edwards. 1990. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol. 64:3770-3778.
41. Rosen, B. 1990. Fundamentals of hiostatistics. PWS-Kent Publishing Co., Boston, Mass.
42. Ross, R. 1986. The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 314:488-500.
43. Sedmak, D., D. Knight, N. Vook, and W. Waldman. 1994. Divergent patterns of ELAM-1. ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 58:1379-1385.
44. Shuper, A., E. P. Vining, and J. M. Freeman. 1990. Central nervous system vasculitis after chicken pox: cause or coincidence? Arch. Dis. Child. 65:1245-1248.
45. Siess, D. C., S. L. Kozak, and D. Kabat. 1996. Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process. J. Virol. 70:3432-3439.
46. Sommerfelt, M. A., S. R. Petteway, G. B. Dreyer, and E. Hunter. 1992. Effect of retroviral protease inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage. J. Virol. 66:4220-4227.
47. Span, A., M. van Dam-Mieras, W. Mullers, J. Endert, A. Muller, and C. Bruggeman. 1991. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Clin. Investig. 21:331-338.
48. Stoica, G., O. Illanes, S. I. Tasca, and P. K. Wong. 1993. Temporal central and peripheral nervous system changes induced by a paralytogenic mutant of Moloney murine leukemia virus TB. Lab. Investig. 69:724-735.
49. Tucker, S. P., and R. W. Compans. 1993. Virus infection of polarized epithelial cells. Adv. Virus Res. 42:187-247.
50. White, M. F. 1985. The transport of cationic amino acids across mammalian cells. Biochim. Biophys. Acta 822:355-364.
51. Wilson, C. A., J. W. Marsh, and M. V. Eiden. 1992. The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to Moloney murine leukemia virus. J. Virol. 66: 7262-7269.
52. Yang, C., and R. W. Compans. 1996. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. J. Virol. 70:248-254.
53. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.
54. Yu, H., N. Soong, and W. F. Anderson. 1995. Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J. Virol. 69:6557-6562.
55. Zhou, Y., M. Leon, M. Waclwiw, J. Popma, T. Finkel, and S. Epstein. 1996. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335:624-630.